CURIS, INC. Common Stock ($0.01 par value per share) Capital on Demand™ Sales AgreementCuris Inc • March 6th, 2020 • Biological products, (no disgnostic substances) • New York
Company FiledMarch 6th, 2020 Industry JurisdictionCuris, Inc. (the “Company”), confirms its agreement (this “Agreement”) with JonesTrading Institutional Services LLC (the “Agent”), as follows: